1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow RP3: new trials by email Literature Review of RP3 trials Research Report on RP3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours RP3, Nivolumab - Advanced Solid Tumor | Phase 1 | Active not recruiting | Replimune, Inc. | 123 | 2020-12-29 | 2026-02-27 |
Replimune, Inc. (1)
France (1) · Greece (1) · Spain (1) · United Kingdom (1) · United States (1)
Gary Vanasse, MD (1)